Learn More
In this Harm Reduction Digest Sheridan, Butler, Wilkins and Russell address the emergent phenomenon of so-called 'legal party pills' which have become a significant drug issue in New Zealand and elsewhere. Although banned in a number of countries, they are currently legally available in New Zealand where they are marketed as 'safe' alternatives' to(More)
BACKGROUND Benzylpiperazine (BZP) is the psychoactive ingredient in a range of 'legal highs' sold worldwide. BZP was prohibited in New Zealand in 2008. AIM To investigate the impact of the prohibition of BZP legal highs on the prevalence of BZP, replacement legal highs and other drugs. METHODS A population survey of BZP and other drugs was conducted in(More)
AIMS To examine changes in the use of ecstasy, current conditions of supply, harms resulting from use, and the demographics of users. METHODS National Drug Surveys were conducted in 1998 and 2001. In each survey, a representative national sample of approximately 5500 people aged 15-45 years were asked about their drug use, including ecstasy use, using a(More)
An intrinsic drawback with the use of a computer-assisted telephone interview (CATI) survey methodology is that people who live in households without a connected landline telephone are excluded from the survey sample. This paper presents a pilot of the feasibility of a computer-assisted cell-phone interview (CACI) methodology designed to survey people(More)
This paper aims to set out some of the policy and public health issues raised by the appearance of a wide range of emergent psychoactive substances of diverse origin, effect and risk profile (commonly referred to as 'legal highs'). It will start by considering what is meant by the term 'legal highs' and consider the historical context that has framed their(More)
INTRODUCTION AND AIMS A large legal market for party pills containing benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) developed in New Zealand after 2004. The use of these party pills has been associated with adverse health effects. The purpose of this paper was to assess a general population sample of party pill users to investigate the(More)
BACKGROUND 'Party' pills containing benzylpiperazine (BZP) and trifluoromethylphenylpiperazine (TFMPP) were sold legally in New Zealand until early 2008. Prospective studies of hospital emergency department admissions appeared to suggest that the harm from party pills was greater among South Island than North Island users. The party pill industry(More)
AIMS To measure the level of heavy amphetamine use, poly drug use, and intravenous drug use by amphetamine users in New Zealand. METHODS Using a Computer Assisted Telephone Interview (CATI) system, a national sample of approximately 5500 people (aged 15-45 years) were interviewed about their recreational drug use. RESULTS Five percent of the sample(More)
AIM To track trends in drug use in the New Zealand population over the past 8 years. METHOD National household surveys of drug use were conducted in New Zealand in 1998, 2001, 2003,and 2006 using the same Computer Assisted Telephone Interview (CATI) methodology. The age ranges of the random digit dial (RDD) samples from each survey wave were truncated to(More)
New data collected on the procurement and purchase of cannabis in the 2001 New Zealand National Drug Survey are used to estimate the dollar value of the illicit market for cannabis as well conduct other economic analyses of the illicit purchase of cannabis in New Zealand. Eighty-four per cent of last-year cannabis users received at least some of their(More)